NeoGenomics sees Q3 revenue of $63.1M, $2.8M shy of consensus; shares ease 1% after hours [Seeking Alpha]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Seeking Alpha
NeoGenomics sees Q3 revenue of $63.1M, $2.8M shy of consensus; shares ease 1% after hoursOn apreliminary basis, NeoGenomics (NASDAQ:NEO) expects Q3 revenue of $63.1M, up 4% yoy but shy of consensus of $65.9M.Non-GAAP EBITDA should be ~$6.0M. Clinical genetic test volume should be ~162.5K.The company says Hurricanes Harvey and Irma depressed revenue $1.0M and non-GAAP EBITDA $1.2M in the quarter. It also expects to record a one-time $1.3M charge to revenue to reflect a change in the process for estimating revenue for unbilled tests at quarter-end.Q3 revenue will be ~$1.3M less than Q2 as a result of the PathLogic divestiture.Preliminary Q4 guidance: Revenue: $65M - 67M; non-GAAP EBITDA: $9M - 10M.Shares are down1% after hours on increased volume.Now read:BioTime readies stock offering; shares down 3% after hours »
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics announces senior leadership promotions [Seeking Alpha]Seeking Alpha
- NeoGenomics Announces Senior Leadership Promotions [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Announces Senior Leadership PromotionsBusiness Wire
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024Business Wire
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
NEO
Earnings
- 2/20/24 - Beat
NEO
Sec Filings
- 4/18/24 - Form 8-K
- 4/8/24 - Form ARS
- 4/8/24 - Form DEFA14A
- NEO's page on the SEC website